For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Radiation + 24mo LHRH | Conformal RT 79.2 Gy(RBE) total dose + 24 months LHRH agonist (androgen suppression). LHRH: Androgen suppression therapy using LHRH agonists such as leuprolide, goserelin, buserelin, triptorelin. Conformal RT: 1.8 Gy(RBE) (or Gy for IMRT) per fraction,five fractions per week for a total dose of 79.2 Gy (RBE) (or Gy). | None | None | 0 | 1 | 1 | 1 | View |
| Radiation + Chemo + 6mo LHRH | Conformal RT 79.2 Gy(RBE) total dose + Chemotherapy: Docetaxel 20mg/m2 x every 7 days x 8 weeks followed by 6 months LHRH (androgen suppression). Docetaxel: Docetaxel 20mg/m2 IV every 7 days x 8 weeks. Conformal RT: 1.8 Gy(RBE) (or Gy for IMRT) per fraction,five fractions per week for a total dose of 79.2 Gy (RBE) (or Gy). | None | None | 0 | 1 | 1 | 1 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| diarrhea | None | Gastrointestinal disorders | None | View |
| dermatitis radiation | None | Skin and subcutaneous tissue disorders | None | View |
| urinary incontinence | None | Renal and urinary disorders | None | View |
| urinary tract pain | None | Renal and urinary disorders | None | View |
| hematuria | None | Renal and urinary disorders | None | View |
| urinary retention | None | Renal and urinary disorders | None | View |
| agitation | None | Psychiatric disorders | None | View |
| fatigue | None | General disorders | None | View |
| hot flashes | None | Vascular disorders | None | View |